TARS Key Financial Ratios - Tarsus Pharmaceuticals, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	3.2	—	-7.60%	-13.40%
2026-03-31	3.74	—	-8.31%	-13.83%
2025-12-31	3.85	—	-11.81%	-19.34%
2025-09-30	4.29	—	-15.18%	-24.22%
2025-06-30	5.26	—	-18.58%	-27.66%
2025-03-31	5.57	—	-20.96%	-30.64%
2024-12-31	4.42	—	-30.65%	-51.46%
2024-09-30	5.42	—	-35.70%	-56.57%
2024-06-30	7.03	—	-39.82%	-59.49%
2024-03-31	8.01	—	-42.43%	-53.85%
2023-12-31	6.93	—	-51.19%	-68.99%
2023-09-30	11.15	—	-40.10%	-50.35%
2023-06-30	12.43	—	-48.14%	-61.57%
2023-03-31	15.74	—	-30.90%	-37.64%
2022-12-31	14.61	—	-27.25%	-32.19%
2022-09-30	16.4	—	-26.79%	-31.26%
2022-06-30	21.36	—	-22.36%	-25.52%
2022-03-31	14.18	—	-24.49%	-29.79%
2021-12-31	15.33	—	-7.73%	-8.29%
2021-09-30	18.05	—	-5.48%	-5.83%
2021-06-30	19.22	—	-2.40%	-2.54%
2021-03-31	18.92	—	-7.47%	-7.90%
2020-12-31	31.68	—	-15.59%	-16.15%
2020-09-30	14.5	—	-18.18%	93.99%
2020-06-30	—	—	—	66.15%
2020-03-31	—	—	—	61.33%
2019-12-31	70.85	—	-8.01%	77.75%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	3.85	—	-11.81%	-19.34%
2024-12-31	4.42	—	-30.65%	-51.46%
2023-12-31	6.93	—	-51.19%	-68.99%
2022-12-31	14.61	—	-27.25%	-32.19%
2021-12-31	15.33	—	-7.73%	-8.29%
2020-12-31	31.68	—	-15.59%	-16.15%
2019-12-31	70.85	—	-8.01%	77.77%
2018-12-31	—	—	—	97.42%